Performance- and time-based payment models - like the one bluebird bio has proposed for LentiGlobin - are especially harder to put into practice in the US than in Europe, some executives said at this week's JPM conference.
Fresh off its MassChallenge win, MIT spinoff SQZBiotech is taking its tech to new heights. Namely, it’s partnered with NASA and will be studying its “cell-squeezing” process at the International Space Station, learning how to better insert transformative materials into cells in a microgravity environment. The startup has developed a slick, vector-free method of introducing material into […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.